Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK drug halves attacks in hard-to-treat asthma
GSK drug halves attacks in hard-to-treat asthma
GSK drug halves attacks in hard-to-treat asthma
Submitted by
admin
on August 17, 2012 - 10:22am
Source:
Reuters
News Tags:
GSK
asthma
mepolizumab
Headline:
GSK drug halves attacks in hard-to-treat asthma
Do Not Allow Advertisers to Use My Personal information
